Harmonic Inc. reports strong Q3 results but faces concerns, leading to a cautious outlook. Click for more on HLIT Stock and its most recent earnings release.

Third Harmonic Bio, Inc. (THRD) closed the last trading session at $15, gaining 20.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...

Harmonic (NASDAQ:HLIT – Get Free Report) was downgraded by Raymond James from a “strong-buy” rating to an “outperform” rating ...

Research analysts at Northland Capmk raised their FY2024 earnings per share (EPS) estimates for Harmonic in a report issued ...

VICTORIA, British Columbia & COLUMBIA, Md., November 13, 2024--(BUSINESS WIRE)--Vecima Networks Inc. (TSX: VCM) and Digital Harmonic, LLC, announced today that Vecima has been named the exclusive ...

SAN JOSE, Calif., Oct. 14, 2024 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced it will release its third quarter 2024 financial results after the market close on Monday, October 28 ...

Tracks on CDs and records have different sound qualities due to physical limitations and mastering processes. CDs are easier ...

The Harmonic Drive is a key part of countless robotic applications. Incredibly simple yet quite odd to watch, this gear system is extremely precise with an impressive torque-to-weight ratio, even if ...

Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases, ...

Robot actuators must generate high torques, but at the same time be light and compact. The ideal application for the Harmonic ...

Third Harmonic Bio, Inc. ( (THRD) ) has released its Q3 earnings. Here is a breakdown of the information Third Harmonic Bio, Inc. presented to ...

SAN FRANCISCO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal ...